2016-08-12T09:40:14-05:00 2015-12-31 Grant Thornton LLP 100 E Wisconsin Ave Milwaukee WI 53202 990 2015-01-01 381550001 Michigan Blood % CHARLEEN MELLO MICH 6167742300 PO Box 1704 Grand Rapids MI 495011704 WILLIAM RIETSCHA PRESIDENT/CEO 4142898200 2016-08-10 true Daniel V Romano P00504182 4142898200 2016-08-10 2015 2016-12-15 16:53:06Z William Rietscha PO Box 1704 Grand Rapids MI 495011704 50983926 false X www.miblood.org X 1955 MI HELPING PEOPLE MAKE A LIFESAVING DIFFERENCE THROUGH BLOOD PRODUCTS AND SERVICE EXCELLENCE 8 7 563 579 0 2206994 413021 41106448 46720288 726014 456307 1898 -78 44041354 47589538 0 36000 0 0 20625588 21286696 0 0 756 21277136 26298185 41902724 47620881 2138630 -31343 33713554 34842679 4246457 6284042 29467097 28558637 X The purpose of Michigan blood is to provide a safe and adequate blood supply and blood-related services for the communities served by hospital partners throughout the state. Michigan blood is the sole provider of blood for 60 hospital facilities. These hospitals include major medical centers (secondary- and tertiary-care teaching facilities) serving populations totaling more than 2.5 million people. Through donor centers and blood drives in northwest, east-central, west, southwest and southeast michigan, michigan blood recruits and collects blood from volunteer donors to achieve its lifesaving mission. Annually, michigan blood collects approximately 126,000 units of blood from volunteer blood donors and distributes 248,000 blood components. false false 42804046 36000 46720288 For over 60 years, Michigan blood has proudly served Michigan hospitals as an independent, community-based, nonprofit blood center. In addition to blood donation, Michigan blood administers a variety of key programs and specialty services that further our lifesaving mission. These services include a nationally recognized center for the national marrow donor program, one of only 25 public cord blood banks in America, and we work alongside local hospitals to deliver a number of medical services and therapeutic procedures. Michigan blood is also affiliated with Versiti, an organization whose members share resources and expertise to improve patient outcomes, as well as conduct leading edge medical research and provide nationwide diagnostic lab services. To learn more about the program services Michigan blood provides please see detailed descriptions below: Blood donation: Volunteer blood donors give blood at nine permanent donor centers throughout Michigan and at blood drives hosted by community organizations and businesses. Each Michigan blood region also operates a self-contained blood center on wheels. These "blood buses" help expand our reach to small communities and urban areas where space is at a premium. See www.miblood.org for a comprehensive list of donation locations. Apheresis: Special equipment makes it possible to collect one or more specific blood components from a donor, while returning the remaining components back to the donor. Apheresis donations allow a greater quantity of one component to be drawn versus a standard whole blood donation. These larger component-specific donations help reduce the number of donors a patient is exposed to, which is preferred by most physicians. Also, patients with diseases such AT TTP, kidney rejection, myasthenia gravis, sickle cell disease, or leukemia can be treated by the removal of one or more blood components using therapeutic apheresis technology. Michigan blood staff and equipment travel to Grand Rapids area hospitals to make this service available as needed. Marrow/stem cell program: In the past 25 years, Michigan blood marrow/stem cell program has established one of the premier donor-recruitment records in the united states, adding more than 64,000 individuals from Michigan with advanced tissue typing to the registry of potential stem cell donors maintained by the be the match registry (national marrow donor program). In 2010, the donor center received the donor management recognition award, a lifetime achievement award. In October 2014, Versiti merged the Wisconsin and Michigan donor centers which are managed from Michigan. The combined donor center handles a registry of 126,000 donors and has facilitated over 1,000 donors for transplants worldwide. Michigan blood has received two $250,000 appropriations from the state of Michigan for the education and typing of Michigan donors. Michigan blood is the first donor center in the country to have a be the match fundraising license plate. The marrow/stem cell program also provides support services for patients and families seeking compatible stem cell donors. Stem cell transplants remain the primary source of hope for patients with certain kinds of life-threatening diseases. Cord blood bank: Michigan blood cord blood bank, the first of its kind in Michigan, has collected and stored blood from more than 3,650 umbilical cords. Cord blood is rich in stem cells and cord blood transplantation is finding increasing application in children and adults around the globe suffering from certain life-threatening diseases. Michigan blood has provided nearly 200 units of life saving cord blood for transplantation. Cellular therapy: As part of ever-changing medical landscape, Michigan blood supports personalized cellular therapy treatments used in a number of cancers and other life-threatening diseases. For instance, Michigan blood collects cells from prostate cancer patients to be used in the preparation of personalized treatments. Other applications are routinely being researched and trialed in hopes of gaining FDA approval. The department also collects patient white cells and processes them with UV light to help treat graft vs. Host disease and cutaneous t-cell lymphoma. Local availability of stem cell collection, processing, storage, and pre-transplant preparation supports the local transplant program's ability to offer advanced medical care. It also offers increased convenience and reduced stress for patients and families who previously had to travel long distances for transplant services. DNA/HLA laboratory: This laboratory uses special techniques to conduct tissue typing at the genetic code level to evaluate donor-patient compatibility before transplantation. Local availability of these services helps doctors respond faster to urgent patient needs caused by aggressive diseases. Patients with transfusion/pregnancy-related sensitivities also benefit from the services of the DNA/HLA laboratory which helps physicians diagnose, treat and find appropriate blood products. The DNA/HLA laboratory also types apheresis donors to identify life-saving matches for patients needing component transfusion. Immunohematology reference laboratory: Patients with complex transfusion-related sensitivities benefit from the services of the immunohematology reference laboratory, which provides information that helps physicians diagnose and treat complicated cases and find rare blood types for transfusion. These patients often are critically ill and may suffer serious complications (including death) without special laboratory services to help their doctors assess the risks of transfusion reactions and donor/recipient incompatibilities. Volunteerism: Michigan blood offers a wide variety of opportunities for community members interested in volunteering their time to help their community and support Michigan blood's lifesaving mission. 42804046 true true false false false false false false false false true true false false false true true true false false false false false false true false false true false true false false false false false false false false true false false false false true false false false true 23 0 true 563 true false false false false false true true false false false false X 8 7 false false false false true true true true true false false true true true true true true true true false MI X CHARLEEN MELLO 6162338613 1036 FULLER NE Grand Rapids MI 49503 Bill Rietscha President/CEO 54.0 1.0 X X 319086 0 31497 Paul D Smith Jr Secretary/Treasurer 1.0 X X 0 0 0 Chuck Downey Chair 1.0 1.0 X X 0 0 0 Mitchell G Watt Vice Chair 1.0 X X 0 0 0 Linda Constantino Director 1.0 X 0 0 0 Paul Keep Director 1.0 X 0 0 0 Jack O'Donnell MD Director 1.0 X 0 0 0 John J Perras Director 1.0 1.0 X 0 0 0 Leeann Wietekamp VP of Medical Services 55.0 X 296788 0 24850 James Wilson Chief Operating Officer 55.0 X 111524 0 7410 Anthony Watkins Sr VP & CFO 7.0 48.0 X 59581 382418 45267 Margaret McElligott VP Quality Services 7.0 48.0 X 35480 227725 61032 Sandi Lemons VP Human Resource Services 6.0 49.0 X 31081 273045 47338 Lynne Briggs VP Information Svcs & CIO 4.0 51.0 X 23055 278713 58588 Maureen Kwiecinski Asst Corporate Secretary 2.0 53.0 X 15759 387285 43301 Michael McMahon VP of Operations 45.0 10.0 X 117793 23569 3689 Robert Eluskie Director of Info Technology 55.0 X 116407 0 26247 Cindy Raven VP of Community Relations 55.0 X 111590 0 20748 Jennifer Lee Bird Director of Reg. Compliance/QA 55.0 X 111411 0 16637 Mary Catherine Lawson Director of Donor Recruitment 55.0 X 108172 0 5603 1457727 1572755 392207 15 false true false 0 10306 19633 220525 162557 55686 413021 BLOOD PRODUCTS/TESTING 621500 40068081 40068081 0 0 SPECIAL SERVICES 621500 6650595 6650595 0 0 MISCELLANEOUS REVENUE 621500 1612 1612 0 0 46720288 400847 400847 0 0 0 0 0 3379313 56521 3374184 6190 5129 50331 55460 55460 7936 10306 13964 -6028 -6028 6000 50 5950 5950 0 0 47589538 46720288 0 456229 36000 36000 0 0 0 981451 981451 0 16227025 14354809 1872216 291939 250484 41455 2569616 2320322 249294 1216665 1037878 178787 0 27478 27478 55651 55651 0 0 40600 40600 429187 48375 380812 220563 192827 27736 525052 276286 248766 305986 16958 289028 0 1196335 1190528 5807 280794 274331 6463 0 208232 89414 118818 76253 76253 0 1437166 1354398 82768 181993 150290 31703 BLOOD PROCESSING SUPPLIES 11146681 11093739 52942 BLOOD IMPORT EXPENSE 7900796 7900796 EQUIPMENT & TRANSPORTATION 1551069 1319624 231445 DONOR RECRUITMENT 327616 326970 188 458 386733 570017 -183582 298 47620881 42804046 4816079 756 2903799 2987192 0 0 133467 30050 3728281 4182559 0 0 0 0 0 0 1427047 2290197 521798 650877 30832887 17314607 11632835 13518280 0 0 13028464 10828666 0 0 0 0 337863 354858 33713554 34842679 2503336 4060130 0 0 0 0 0 0 0 0 0 0 1743121 2223912 0 0 0 0 4246457 6284042 X 29442451 28464544 14496 83943 10150 10150 29467097 28558637 33713554 34842679 X -31343 -877117 X false true X true false X 62335 97964 98507 2206994 413021 2878821 41063808 40481179 21965633 41106448 46720288 191337356 0 0 0 41126143 40579143 22064140 43313442 47133309 194216177 0 22151735 22220741 11144406 20402773 20475467 96395122 22151735 22220741 11144406 20402773 20475467 96395122 97821055 276187 319140 268012 452545 400847 1716731 0 276187 319140 268012 452545 400847 1716731 0 18173 20595 10882 18881 13936 82467 41420503 40918878 22343034 43784868 47548092 196015375 0.49905 0.46810 0.00876 0.00939 X Part III Public Support Test Calculation With the filing of the 2014 Form 990, the filing organization has made some modifications to methodology for calculating the Part III Public Support percentage. Michigan blood has various contracts in place with hospitals that enable those hospitals to have the necessary blood product supplies on hand. However, due to various regulatory limitations the filing organization is not permitted to bill the hospital patients directly for these Blood products. In order to clearly reflect the agency relationship with the hospitals, historical contracts have been and will continue to be revised to clarify that the patient is the actual consumer of these blood products. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2546071 2546071 14076702 7775175 6301527 916863 304926 611937 10570174 7274340 3295834 2723077 1960166 762911 13518280 MUTUAL FUNDS 10828666 F 10828666 0 0 X 46676188 -877117 84 14014 -863019 47539207 50331 50331 47589538 47584648 84 14014 14098 47570550 50331 50331 47620881 Part X Income Taxes The Organization has received a tax determination letter confirming that the Organization qualifies as a tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code (the Code). Management believes that there are no material uncertain tax positions that require recognition in the financial statements. The Organization, while generally exempt from income tax, is subject to tax on income unrelated to their exempt purposes, unless that income is otherwise excluded by the Code. The Organization has not historically filed any unrelated business income tax returns; therefore, tax years remain open for years in which an income tax return has not been filed. The Organization recognizes, if necessary, interest and penalties related to unrecognized tax benefits in the provision for income taxes. There were no interest or penalties related to income taxes that have been accrued or recognized as of and for the years ended December 31, 2015 and 2014. Part XI, Line 2d Other Changes to Revenue Fundraising Expenses Reported with Revenue 13,964 Gaming Expenses Reported with Revenue 50 ------- Total 14,014 Part XI, Line 4B Other Changes to Revenue Gain on Sale of Fixed Assets Reported with Revenue 50,331 Part XII, Line 2d Other Changes to Expenses Fundraising Expenses Reported with Revenue 13,964 Gaming Expenses Reported with Revenue 50 ------- Total 14,014 Part XII, Line 4B Other Changes to Expenses Gain on Sale of Fixed Assets Reported with Revenue 50,331 Golf Outing 18242 10306 7936 126 5280 3625 4933 0 18242 10306 7936 126 5280 3625 4933 13964 -6028 true Central Indiana Regional Blood Center 3450 N Meridian ST Indianapolis IN 46208 350991629 36000 Scholarships 1 Part I, Line 2 Procedure for Monitoring Use of Grant Funds inside U.S. Michigan Blood provides grant assistance to other organizations. These funds will support future blood research and other initiatives to serve more patients and reduce overall costs. Monitoring the investment of these funds, the distributions and what these funds are used for is completed by the leadership of Versiti. X X X false false false false false false false true false Bill Rietscha President/CEO 264060 0 0 0 55026 0 10200 0 21297 0 350583 0 0 0 Leeann Wietekamp VP of Medical Services 261080 0 0 0 35708 0 10200 0 14650 0 321638 0 0 0 Anthony Watkins Sr VP & CFO 44486 285533 13154 84426 1941 12459 2762 17722 3341 21442 65684 421582 0 0 Margaret McElligott VP Quality Services 26133 167741 6510 41784 2837 18200 5400 34660 2827 18145 43707 280530 0 0 Sandi Lemons VP Human Resource Services 25148 220919 5845 51355 88 771 2878 25287 1960 17213 35919 315545 0 0 Lynne Briggs VP Information Svcs & CIO 18601 224860 4273 51672 181 2181 2637 31868 1841 22242 27533 332823 0 0 Maureen Kwiecinski Asst Corporate Secretary 12052 296201 2978 73185 729 17899 1406 34545 288 7062 17453 428892 0 0 Part I, Line 7 Non-Fixed Payments Incentive payout opportunities, based on percentage of base pay rate, are available to certain employees of the filing organization. While levels of the incentive payout opportunity are fixed and determined percentages of base compensation; the incentive payout is subject to the review of accomplishments/objectives and the ultimate determination of incentive compensation is subject to president/CEO and executive committee of the board approval. X Gift Cards 1 47000 FMV X Auction items 57 8686 FMV false false false Part VI, Section A, Line 6 Members or Stockholders VERSITI, INC. (A 501(C)(3) ORGANIZATION) IS THE SOLE CORPORATE MEMBER. Part VI, Section A, Lines 7a and 7b Member or Stockholder Powers VERSITI, INC. HAS RESERVE POWERS, INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. Part VI, Section B, Line 11b Form 990 Review Michigan blood utilizes grant Thornton LLP to complete the IRS form 990 and related schedules. Following completion, they are reviewed by the finance/audit committee. The full board is provided a copy of the form 990 prior to filing. Part VI, Section B, Line 12c Conflict of Interest Policy Annually conflict of interest statements are completed by all board of directors and key members of the management team. Responses are compiled by VERSITIs legal services team to determine if any conflicts exist. Identified conflicts are addressed in accordance with the policy. Part VI, Section B, Lines 15a and 15B Compensation Process THE COMPENSATION COMMITTEE OF THE VERSITI BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR VERSITI AND THE RELATED ENTITIES THAT IT SUPPORTS, INCLUDING MICHIGAN BLOOD. OTHER THAN THE VERSITI PRESIDENT & CHIEF EXECUTIVE OFFICER, THE COMPENSATION COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT AND IS COMPRISED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI OR MICHIGAN BLOOD COMPENSATION ARRANGEMENTS. THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE VERSITI COMPENSATION COMMITTEE REVIEWS MICHIGAN BLOOD EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. THE COMPENSATION COMMITTEE ASSESSES THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS AFTER IT OBTAINS AND REVIEWS APPROPRIATE DATA FOR COMPARABILITY FROM THE HUMAN RESOURCE DEPARTMENT AND AN INDEPENDENT COMPENSATION CONSULTANT. THE COMPENSATION COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE COMPENSATION COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE COMPENSATION COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. VERSITI AND MICHIGAN BLOOD HAVE INCENTIVE PROGRAMS FOR THE CHIEF EXECUTIVE OFFICER AND OTHER CORPORATE OFFICERS DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE COMPENSATION COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE/COMPENSATION COMMITTEE EVALUATES THE VERSITI/MICHIGAN BLOOD CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -OTHER CORPORATE OFFICERS - EACH YEAR, THE VERSITI/MICHIGAN BLOOD CEO REVIEWS THE PERFORMANCE AND THE ACHIEVEMENT OF INDIVIDUAL GOALS AND OBJECTIVES OFEACH VERSITI/MICHIGAN BLOOD CORPORATE OFFICER. THE VERSITI/MICHIGAN BLOOD CEO PRESENTS HIS/HER RECOMMENDATIONS TO THE COMPENSATION COMMITTEE, WHICH REVIEWS AND APPROVES RECOMMENDED COMPENSATION RANGES, AND APPROVES FINAL SALARY AND INCENTIVE PAYMENTS. CORPORATE OFFICERS ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET Part VI, Section C, Line 19 Organization's Documents Open to the Public Michigan blood makes its governing documents, conflict of interest policy and financial statements available to the public upon request. Part VII Average Hours The hours lsited on form 990, part vii are representative of an average for the officers and executive team. each individual person's weekly tally may be greater or lesser per week based on their individual roles and responsibilities within the filing organization and related parties. BLOODCENTER OF WISCONSIN INC 638 NORTH 18TH MILWAUKEE WI 532332121 390807235 BLOOD WI 501(C)(3) 07 VERSITI false BLOODCENTER RESEARCH FOUNDATION INC PO BOX 2178 638 NORTH 18TH MILWAUKEE WI 53201 391372542 SUPPORTING WI 501(C)(3) 11B BLOODCENTER false VERSITI INC PO BOX 2178 638 NORTH 18TH MILWAUKEE WI 53201 454675354 SUPPORTING WI 501(C)(3) 11B NA false AURORA AREA BLOOD BANK DBA HEARTLAND 1200 N HIGHLAND AVENUE AURORA IL 60506 362179768 BLOOD WI 501(C)(3) 09 BLOODCENTER false CENTRAL INDIANA REGIONAL BLOOD CENTER 3450 NORTH MERIDIAN STREET INDIANAPOLIS IN 46208 350991629 BLOOD IN 501(C)(3) 09 VERSITI false false true true false false false false false false false false true true false true true false false false